Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients
- PMID: 34382669
- DOI: 10.5603/NMR.2021.0016
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients
Abstract
Background: To evaluate the diagnostic performance of [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography ([¹⁸F]FDG-PET/CT) scan in detecting local recurrences in patients with surgically treated oral tongue squamous cell cancer (OTSCC).
Material and methods: Eighty-seven patients who had undergone surgery for OTSCC were monitored clinically and [¹⁸F]FDGPET/CT and magnetic resonance (MR). PET uptakes were classified as functional (Type A), suspicious (Type B), or highly suggestive of local recurrence (Type C). A multidisciplinary team (MDT) evaluated case-by-case the surveillance strategy based on PET uptake.
Results: Fifty-nine patients presented FDG-PET uptake during follow-up: this report was significantly more frequent in patients who received flap reconstruction than in those without (73% vs 50%; p = 0.05). In 13 patients with Type A (n = 1), Type B (n = 9), and Type C (n = 3) uptakes an additional MR was considered preferable and discovered recurrence in 12.PET-CT had 9 true positives, 17 false positives, 71 true negatives, and no false-negative, resulting in sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of 100%, 80.7%, 34.6%, and 100%.
Conclusions: The present results demonstrated a change in diagnostic strategy, as decided by the MDT, in about one-fifth of patients. The results should prompt in designing a rational surveillance schedule in surgically treated OTSCC.
Keywords: PET/CT; [18F]FDG PET/CT; magnetic resonance imaging; tongue carcinoma.
Similar articles
-
Use of Diffusion-Weighted Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.Clin Oncol (R Coll Radiol). 2018 Dec;30(12):780-792. doi: 10.1016/j.clon.2018.09.007. Epub 2018 Oct 11. Clin Oncol (R Coll Radiol). 2018. PMID: 30318343
-
Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study.Dentomaxillofac Radiol. 2023 Oct;52(7):20230083. doi: 10.1259/dmfr.20230083. Epub 2023 Sep 4. Dentomaxillofac Radiol. 2023. PMID: 37494001 Free PMC article.
-
Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.JAMA Otolaryngol Head Neck Surg. 2018 Nov 1;144(11):1037-1043. doi: 10.1001/jamaoto.2018.2143. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 30242338 Free PMC article.
-
Squamous cell carcinoma of the tongue with cardiac metastasis on 18F-FDG PET/CT: A case report and literature review.Medicine (Baltimore). 2021 Apr 16;100(15):e25529. doi: 10.1097/MD.0000000000025529. Medicine (Baltimore). 2021. PMID: 33847677 Free PMC article. Review.
-
18 F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.Head Neck. 2019 Feb;41(2):551-561. doi: 10.1002/hed.25513. Epub 2018 Nov 20. Head Neck. 2019. PMID: 30456825
Cited by
-
Correlation of preoperative 18F-FDG-PET/CT tumor staging and maximum standardized uptake values with preoperative CT, postoperative tumor classification, and histopathological parameters of oral squamous cell carcinoma.Clin Oral Investig. 2025 Mar 18;29(4):189. doi: 10.1007/s00784-025-06252-1. Clin Oral Investig. 2025. PMID: 40100406
-
Post-treatment surveillance imaging in head and neck cancer: a systematic review.Insights Imaging. 2024 Feb 5;15(1):32. doi: 10.1186/s13244-023-01578-4. Insights Imaging. 2024. PMID: 38315325 Free PMC article. Review.
-
Reconstructive flap surgery in head and neck cancer patients: an interdisciplinary view of the challenges encountered by radiation oncologists in postoperative radiotherapy.Front Oncol. 2024 Apr 11;14:1379861. doi: 10.3389/fonc.2024.1379861. eCollection 2024. Front Oncol. 2024. PMID: 38665951 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical